Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan + doxycycline regimens for Helicobacter pylori eradication in penicillin-allergic patients
ChiCTR2600116496Phase 4Not yet recruiting
- Sponsor
- Changzhou Second People's Hospital
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of vonoprazan and doxycycline in Helicobacter pylori infection (3 arms), sponsored by Changzhou Second People's Hospital. Primary endpoint: Eradication rate. Planned start Jan 2026; status: not yet recruiting.
02
Drugs
vonoprazandoxycycline
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on ChiCTR2600116496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600116496.